COMMUNIQUÉS West-GlobeNewswire

BriaCell Announces Closing of Upsized Non-Brokered Private Placement of $846,301.49
09/09/2019
BERKELEY, Calif. and VANCOUVER, British Columbia, Sept. 09, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF) , a clinical-stage biotechnology company [...]
RespireRx Pharmaceuticals Inc. Executives Participating in the 2nd Annual International Cannabinoid Derived Pharmaceuticals Summit
09/09/2019
September 10 – 12, 2019 Workshops, September 10, 2019 Aloft Boston Seaport District 401-403 D. St., Boston, MA 02210 Executive Chairman/CSO/Interim CEO participating as a workshop leader on Cannabinoid Formulations- [...]
Apellis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09/09/2019
CRESTWOOD, Ky., and WALTHAM Mass., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Apellis Pharmaceuticals Inc., (Nasdaq:APLS) a clinical-stage biopharmaceutical company focused on the development of novel therapeutic compounds to [...]
OrthoPediatrics Corp. Announces U.S. Launch of Next Generation Cannulated Screw Systems
09/09/2019
WARSAW, Indiana, Sept. 09, 2019 (GLOBE NEWSWIRE) -- OrthoPediatrics Corp. (“OrthoPediatrics”) (NASDAQ: KIDS), a company focused exclusively on advancing the field of pediatric orthopedics, is pleased to announce the U.S [...]
Cerner Executive Jeff Townsend Announces Retirement
09/09/2019
KANSAS CITY, Mo., Sept. 09, 2019 (GLOBE NEWSWIRE) -- Cerner Corporation (Nasdaq: CERN) announced today that Jeff Townsend, executive vice president and chief of innovation, will retire by the end of the year, following [...]
Translate Bio Announces Pipeline Program Update
09/09/2019
- Prioritizing and expanding pulmonary disease programs based on early positive cystic fibrosis (CF) data for MRT5005, the first inhaled mRNA therapeutic – - Discontinuing development of MRT5201, a liver-targeted [...]
Flexion Therapeutics and Xenon Pharmaceuticals Announce Flexion’s Acquisition of an Investigational NaV1.7 Inhibitor for the Treatment of Post-Operative Pain
09/09/2019
Flexion’s new locally delivered product candidate, FX301, will combine Xenon’s NaV1.7 inhibitor, XEN402, with a novel thermosensitive hydrogel FX301 is a potential first-in-class therapy with the aim of providing pain [...]
Mental Health Commission of Canada e-mental health report provides roadmap for reducing wait times and improving care
09/09/2019
From Mental Health Commission of Canada , Government of Newfoundland and Labrador , and Memorial University ST. JOHN’S, Newfoundland and Labrador, Sept. 09, 2019 (GLOBE NEWSWIRE) -- Today, the Mental Health Commission [...]
Un rapport de la Commission de la santé mentale du Canada sur la cybersanté mentale trace la voie pour réduire les temps d’attente et améliorer les soins de santé
09/09/2019
De la Commission de la santé mentale du Canada , du gouvernement de Terre-Neuve-et-Labrador , et de l’Université Memorial ST. JOHN'S, Terre-Neuve-et-Labrador, 09 sept. 2019 (GLOBE NEWSWIRE) -- Aujourd’hui, la Commission [...]
Crossject : Résultats semestriels et point sur l'activité
09/09/2019
Communiqué de Presse Résultats semestriels 2019 et point d’activité Avancées significatives sur le semestre Signature d’un contrat de commercialisation et poursuite des négociations commerciales Confirmation de l’ [...]
Neovacs : 2019 Financial Calendar
09/09/2019
PRESS RELEASE PRESS RELEASE PRESS RELEASE 2019 Financial Calendar Paris, September 9, 2019, 5:45 pm CEST – NEOVACS (Euronext Growth Paris: ALNEV) leader in active immunotherapy for the treatment of auto-immune and [...]
Néovacs : Agenda financier 2019
09/09/2019
COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE · COMMUNIQUE DE PRESSE Agenda financier 2019 Paris et Boston, le 9 septembre 2019 – 17h45 CEST - Néovacs (Euronext Growth Paris : ALNEV), leader de l'immunothérapie active [...]
Spineway : Notice of the Ordinary and Extraordinary General Shareholders’ Meeting to be held 19 september 2019
09/09/2019
Notice of the Ordinary and Extraordinary General Shareholders’ Meeting to be held 19 september 2019 Arrangements for availability of preparatory documents Spineway’s General Shareholders’ Meeting called for 9 a.m. on 16 [...]
SPINEWAY : Convocation à l'Assemblée Générale Mixte du 19 septembre 2019
09/09/2019
Convocation à l'Assemblée Générale Mixte du 19 septembre 2019 Modalités de mise à disposition des documents préparatoires L'Assemblée Générale des actionnaires de Spineway, convoquée le 16 août 2019 à 9 heures au siège [...]
Oxurion NV Reports Additional Positive Topline Data from Phase 1 with THR-149, a Novel, Potent Plasma Kallikrein Inhibitor for DME
09/09/2019
Immediate onset of action - starting from Day 1 with increasing average improvement in Best Corrected Visual Acuity (BCVA) of up to 7.5 letters at Day 14 following a single injection of THR-149. Prolonged durability of [...]
GRAChIE Earns Community Partnership Award For Work During Hurricanes Irma and Florence
09/09/2019
Georgia HIE recognized for establishing rapid connections to facilitate access to vital health data SANDERSVILLE, Ga., Sept. 09, 2019 (GLOBE NEWSWIRE) -- The Georgia Regional Academic Community Health Information [...]
Improving Vitamin D level, physical fitness, and body weight may help to reduce health risks in African-American adults
09/09/2019
DALLAS, Sept. 09, 2019 (GLOBE NEWSWIRE) -- An estimated 40% of American adults may be vitamin D deficient. For African-Americans, that number may be nearly double at 76% according to a new study by The Cooper Institute [...]
Holding(s) in Company TR-1: Standard form for notification of major holdings
09/09/2019
LONDON, Sept. 09, 2019 (GLOBE NEWSWIRE) -- TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i [...]
Transactions under Novozymes’ stock buyback program
09/09/2019
Please read the full announcement in the attached PDF Attachment 2019_34_Stock_Buybackprogram_EN

Pages